Murepavadin Enhances the Killing Efficacy of Ciprofloxacin against <i>Pseudomonas aeruginosa</i> by Inhibiting Drug Efflux

<i>Pseudomonas aeruginosa</i> is a multidrug-resistant Gram-negative pathogen and one of the leading causes of ventilator-associated pneumonia and infections in patients with chronic obstructive pulmonary disease and cystic fibrosis. Murepavadin is a peptidomimetic that specifically targ...

Full description

Bibliographic Details

Published in:	Antibiotics
Main Authors:	Xiaoya Wei, Dandan Zhou, Congjuan Xu, Ping Chen, Shuiping Chen, Zhihui Cheng, Yongxin Jin, Shouguang Jin, Weihui Wu
Format:	Article
Language:	English
Published:	MDPI AG 2024-08-01
Subjects:	murepavadin <i>Pseudomonas aeruginosa</i> ciprofloxacin
Online Access:	https://www.mdpi.com/2079-6382/13/9/810